MSD and Eisai presented the data at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The ...
MSD exercises its option on vaccine candidate EVX-B3 for a cash payment of $7.5 million, which extend Evaxion’s cash runway to first half of 2027 MSD will assume full responsibility for the further ...
GlobalData on MSN
MSD’s HIV duo non-inferior to SoC in Phase III trials
MSD’s investigational two-drug HIV combination has been proven safe, efficacious and non-inferior to current standard of care ...
The biopharmaceutical company lycera has announced a collaboration agreement with Merck, Sharpe & Dohme (MSD) that will focus on developing and commercializing small-molecule therapies for treating a ...
The company will expand its production facilities in Carlow and Cork to meet increased global demand for its medicines and vaccines produced in Ireland. MSD, known as Merck in the US and Canada, ...
COPENHAGEN - Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage TechBio company, has entered into an option and license agreement with pharmaceutical giant MSD, known as Merck & Co., Inc. in the U.S ...
What if we had an ergonomics standard? What if business understood the value of ergonomics? How would that impact workplace safety? Reflection is a very powerful tool. Stealing away some quiet time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback